Testing effectiveness (Phase 2)Study completedNCT00575471
What this trial is testing
Placebo Controlled Dose-Response Study of Rivoglitazone in Type 2 Diabetes
Who this might be right for
Type 2 Diabetes
Daiichi Sankyo Co., Ltd. 250
Showing 11 of 11 results